Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma
Status:
Recruiting
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
This research study is investigating Binimetinib and Belinostat in participants with
metastatic uveal melanoma. The research study will test the study drugs to see if the
combination of binimetinib and belinostat can make tumors shrink or stop growing.
Phase:
Phase 2
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute